drugset / Trial / NCT03850379

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

NCT03850379

Phase 2 Completed 308 enrolled Henry Ford Health System
RandomizedParallel-groupOpen-labelPrevention

Summary

Ciprofloxacin and levofloxacin are both in guidelines to use for prophylaxis in autologous and allogeneic Stem cell transplant.Ciprofloxacin was recently replaced by levofloxacin as the preferred agent in some transplant centers. In some small retrospective studies ciprofloxacin prophylaxis was associated with a higher rate of breakthrough gram positive bloodstream infections. However, the optimum oral agent for antibacterial prophylaxis in transplant recipients remains uncertain.

Timeline

Start
2018-03-14
Primary completion
2024-08-30
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 500 mg
Subject Levofloxacin Small molecule 500 mg